Drug-associated renal dysfunction and injury (Q34560483)

3 August 2017

1 reference

title

Drug-associated renal dysfunction and injury (English)

1 reference

3 August 2017

Devasmita Choudhury

1 reference

3 August 2017

Ziauddin Ahmed

series ordinal

1 reference

3 August 2017

publication date

1 February 2006

1 reference

Nature Clinical Practice Nephrology

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

80-91

1 reference

Biologic markers for the early detection of acute kidney injury

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Diuretic therapy and resistance in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Oral cyclosporine but not tacrolimus reduces renal transplant blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Antiviral drug-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Drug-induced thrombotic microangiopathy: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Inherited hemolytic uremic syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Anticancer drug-induced kidney disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Gemcitabine-associated hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

21 January 2018

ATHEROMATOUS EMBOLISM.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Cholesterol crystal embolization: a review of 221 cases in the English literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Nephrotoxicity of several newer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Cisplatin-associated nephrotoxicity and pathological events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Etidronate (EHDP) inhibits osteoclastic-bone resorption, promotes apoptosis and disrupts actin rings in isolate-mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Intravenous immunoglobulin and the kidney--a two-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Anuric acute renal failure caused by dextran 40 administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Liposomal amphotericin B: clinical experience and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Safety of gadolinium contrast angiography in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Drug-induced acute interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Telithromycin-induced acute interstitial nephritis: a first case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Acute interstitial nephritis due to pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Acute interstitial nephritis: clinical features and response to corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Renal syndromes associated with nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Renal atrophy associated with long-term treatment with indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Drug-induced renal calculi: epidemiology, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Retroperitoneal fibrosis during treatment with methydopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Analgesic nephropathy: Etiology, clinical syndrome, and clinicopathologic correlations in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Relevance of animal models to analgesic-associated renal papillary necrosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Altered expression of selected genes in kidney of rats with lithium-induced NDI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Azotaemia Aggravated by Tetracycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

Drug-associated acute renal failure. A prospective collaborative study of 81 biopsied patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Low fractional excretion of sodium with contrast media-induced acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

FK506-associated thrombotic microangiopathy: report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Renal failure and hemolytic anemia associated with mitomycin C. A case report

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Aminoglycoside nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Symptomatic Hypomagnesemia Associated with Gentamicin Therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Contrast-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Indinavir crystal deposits associated with tubulointerstitial nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Retroperitoneal fibrosis after long-term daily use of ergotamine

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Analgesic abuse and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0076

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0076

1 reference

3 August 2017

1 reference